IFM Investors’s CME Group CME Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $18.6M | Buy |
84,021
+10,865
| +15% | +$3.01M | 0.12% | 139 |
|
|
2026
Q1 | $21.6M | Buy |
73,156
+3,304
| +5% | +$981K | 0.18% | 103 |
|
|
2025
Q4 | $19.1M | Buy |
69,852
+518
| +0.7% | +$141K | 0.16% | 110 |
|
|
2025
Q3 | $18.7M | Sell |
69,334
-27
| -0% | -$7.35K | 0.16% | 106 |
|
|
2025
Q2 | $19.1M | Buy |
69,361
+2,798
| +4% | +$761K | 0.18% | 106 |
|
|
2025
Q1 | $17.7M | Hold |
66,563
| – | – | 0.19% | 104 |
|
|
2024
Q4 | $15.5M | Sell |
66,563
-6,653
| -9% | -$1.53M | 0.16% | 115 |
|
|
2024
Q3 | $16.2M | Buy |
73,216
+151
| +0.2% | +$31.2K | 0.16% | 124 |
|
|
2024
Q2 | $14.4M | Buy |
73,065
+774
| +1% | +$160K | 0.15% | 126 |
|
|
2024
Q1 | $15.6M | Sell |
72,291
-450
| -0.6% | -$94.5K | 0.17% | 111 |
|
|
2023
Q4 | $15.3M | Sell |
72,741
-986
| -1% | -$210K | 0.19% | 105 |
|
|
2023
Q3 | $14.8M | Buy |
73,727
+1,948
| +3% | +$387K | 0.19% | 100 |
|
|
2023
Q2 | $13.3M | Buy |
71,779
+5,681
| +9% | +$1.05M | 0.17% | 113 |
|
|
2023
Q1 | $12.7M | Buy |
66,098
+1,973
| +3% | +$357K | 0.19% | 105 |
|
|
2022
Q4 | $10.8M | Buy |
64,125
+1,453
| +2% | +$253K | 0.18% | 118 |
|
|
2022
Q3 | $11.1M | Buy |
62,672
+1,606
| +3% | +$317K | 0.2% | 104 |
|
|
2022
Q2 | $12.5M | Buy |
61,066
+4,139
| +7% | +$877K | 0.22% | 94 |
|
|
2022
Q1 | $13.5M | Buy |
56,927
+10,805
| +23% | +$2.54M | 0.21% | 96 |
|
|
2021
Q4 | $10.5M | Sell |
46,122
-609
| -1% | -$134K | 0.19% | 101 |
|
|
2021
Q3 | $9.04M | Sell |
46,731
-123
| -0.3% | -$24.9K | 0.19% | 107 |
|
|
2021
Q2 | $9.96M | Buy |
46,854
+8,057
| +21% | +$1.7M | 0.2% | 101 |
|
|
2021
Q1 | $7.92M | Buy |
38,797
+4,233
| +12% | +$834K | 0.21% | 98 |
|
|
2020
Q4 | $6.29M | Buy |
34,564
+5,107
| +17% | +$869K | 0.2% | 102 |
|
|
2020
Q3 | $4.93M | Buy |
29,457
+3,049
| +12% | +$514K | 0.21% | 99 |
|
|
2020
Q2 | $4.29M | Sell |
26,408
-9,180
| -26% | -$1.65M | 0.22% | 95 |
|
|
2020
Q1 | $6.19M | Sell |
35,588
-1,245
| -3% | -$248K | 0.28% | 76 |
|
|
2019
Q4 | $7.39M | Sell |
36,833
-1,658
| -4% | -$340K | 0.26% | 82 |
|
|
2019
Q3 | $8.13M | Buy |
38,491
+13,445
| +54% | +$2.81M | 0.3% | 70 |
|
|
2019
Q2 | $4.86M | Buy |
25,046
+1,788
| +8% | +$330K | 0.28% | 74 |
|
|
2019
Q1 | $3.83M | Buy |
23,258
+2,724
| +13% | +$482K | 0.25% | 87 |
|
|
2018
Q4 | $3.86M | Buy |
20,534
+2,667
| +15% | +$493K | 0.31% | 71 |
|
|
2018
Q3 | $3.04M | Buy |
17,867
+2,579
| +17% | +$434K | 0.23% | 96 |
|
|
2018
Q2 | $2.51M | Buy |
15,288
+4,635
| +44% | +$757K | 0.24% | 94 |
|
|
2018
Q1 | $1.72M | Buy |
10,653
+1,122
| +12% | +$179K | 0.25% | 93 |
|
|
2017
Q4 | $1.39M | Buy |
9,531
+32
| +0.3% | +$4.56K | 0.22% | 106 |
|
|
2017
Q3 | $1.29M | Buy |
9,499
+208
| +2% | +$26.3K | 0.22% | 110 |
|
|
2017
Q2 | $1.16M | Buy |
9,291
+2,473
| +36% | +$296K | 0.21% | 113 |
|
|
2017
Q1 | $810K | Buy |
6,818
+2,545
| +60% | +$306K | 0.2% | 118 |
|
|
2016
Q4 | $493K | Buy |
+4,273
| New | +$476K | 0.23% | 116 |
|
Other funds holding CME
PAM
SP
RG
HCM
CF
OIAM
SI
IFM Investors's CME Position: Q2 2026 in Review
IFM Investors increased its CME Group (CME) stake by 15% in Q2 2026, buying an estimated $3.01M and bringing the position to 84,021 shares worth $18.6M. The position accounts for 0.12% of the portfolio, ranked #139.
IFM Investors first reported a position in CME in Q4 2016 and has held it in 39 quarters since. The position peaked at $21.6M in Q1 2026. 401 funds tracked by Wall St. Rank hold CME as of Q2 2026.
- IFM Investors held 84,021 shares of CME Group worth $18.6M as of Q2 2026.
- IFM Investors bought 10,865 CME Group shares in Q2 2026, an estimated $3.01M.
- CME Group made up 0.12% of IFM Investors's portfolio in Q2 2026, its #139 holding.
- IFM Investors first reported a position in CME Group in Q4 2016 and has held it in 39 quarters since.
- IFM Investors's CME Group position peaked at $21.6M in Q1 2026.
- 401 funds tracked by Wall St. Rank held CME Group as of Q2 2026.
Based on IFM Investors's 13F filing for Q2 2026, filed 21 Jul 2026.